SOPHARMA AD: Notification of sale of treasury shares

2025-09-05 09:14

publikacja
2025-09-05 09:14

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Current_report_140_treasury_shares_espi.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		140	/	2025
Date of issue:	2025-09-05
Short name of the issuer
SOPHARMA AD
Subject
Notification of sale of treasury shares
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, September 5, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 4, 2025 the Company sold 67 700 (sixty-seven thousand seven hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 184 903.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.73.
Annexes
File			Description
Current report_140_treasury_shares_espi.pdfCurrent report_140_treasury_shares_espi.pdf			Notification of sale of treasury shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2025-09-05	Ognian Donev	Executive Director

Ważne linki